ACLIRES is a full-service boutique Contract Research Organization (CRO) with GCP-certified clinical units in Latin America and Southeast Asia conducting therapeutic Phase I/II/III clinical trials and medical device studies based on international drug development standards(ICH/FDA/EMA/MHLW).
Contact Details
27th Floor, Bangkok City Tower
179 South Sathorn Rd., Sathorn
Bangkok 10120 · Thailand
Tel: +66 (0)2 412 1315
website: http://www.aclires.com/information/asia.html
ACLIRES’ senior vice president explains the organization’s ambitions to promote Thailand as a unique place for early phase studies, the company’s partnership with Mahidol University and Siriraj Hospital and its dedication…
PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart some of their career progressions since then. …
Unclear licensing rules raise concerns that big foreign firms applying for patents might squeeze out local players and drive up the cost of cannabis-derived medical products. Last week, Thailand’s…
Thailand has long been an active participant in vaccine R&D and is increasingly aware of the importance of self-reliance in vaccine production. Through government support and regional cooperation, Thailand is…
Today’s global interconnectedness requires fast and reliable delivery of goods. DHL Thailand and Indochina Managing Director, Chananyarak Phetcharat, explains the global-reaching organization’s strategy to facilitate safe and dependable delivery of…
Thailand’s healthcare system has been a shining example to its neighbours and ensures all Thai citizens have access to nearly-free basic coverage. However, the system has strained public finances and…
Thailand, with its modern and relatively cheap healthcare, has become a major destination for medical tourism. This trend brings billions of dollars into the Thai economy but the higher wages…
The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International companies must however adapt their strategies to suit the…
Despite political instability, Thailand’s healthcare sector has great prospects for growth due to its expanding middle class, public health service, supply of affordable medicine, and forthcoming membership of the…
Through greater government support for R&D, tax breaks for both foreign investors and domestic researchers and the creation of knowledge clusters, Thailand hopes to reposition itself as a regional R&D…
Thailand is not traditionally known to be a manufacturing center due to its ever-changing policies, but OLIC (Thailand) Limited has risen as the nation’s number one contract manufacturing organization (CMO).…
The Government Pharmaceutical Organization’s Managing Director, Dr. Nopporn Cheanklin, tells PharmaBoardroom about its plans to launch 20 new products, its seaarch for medicines whose patents expire in the next few…
Pfizer is now the number one pharmaceuticals company in Thailand. We spoke to Christian Malherbe, Country Lead for IndoChina, which includes Myanmar, Laos, and Cambodia, about how he is making…
See our Cookie Privacy Policy Here
